Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Pulmonary Fibrosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01755936
What this trial is testing

The Role of Myocardial Fibrosis in Patients With Aortic Stenosis

Who this might be right for
Aortic Stenosis
University of Edinburgh 203
Testing effectiveness (Phase 2)Looking for participantsNCT05892614
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

Who this might be right for
Interstitial Lung Disease
aTyr Pharma, Inc. 25
Not applicableStudy completedNCT02151435
What this trial is testing

Prospective Evaluation of Biomarker Profiles in Idiopathic Pulmonary Fibrosis

Who this might be right for
IPF
University of Michigan 43
Testing effectiveness (Phase 2)Study completedNCT01136174
What this trial is testing

Safety and PK Study of BIBF 1120 in Japanese Patients With IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 50
Not applicableStudy completedNCT06909968
What this trial is testing

Identification of Palliative Care Needs and Prognostic Factors of Survival in Tailoring Appropriate Interventions in Advanced Oncological, Renal and Pulmonary Diseases

Who this might be right for
CancerChronic Renal FailureChronic Obstructive Pulmonary Disease+1 more
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 178
Not applicableUnknownNCT05007340
What this trial is testing

ILD-SARDs Registry and Biorepository

Who this might be right for
Interstitial Lung DiseaseSystemic Autoimmune DiseaseRheumatic Diseases+6 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 252
Not applicableStudy completedNCT01695408
What this trial is testing

Investigating Significant Health Trends in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Technische Universität Dresden 1,232
Not applicableUnknownNCT03229343
What this trial is testing

Impact of a Systematic Palliative Care on Quality of Life, in Advanced Idiopathic Pulmonary Fibrosis.

Who this might be right for
Idiopathic Pulmonary Fibrosis
Assistance Publique - Hôpitaux de Paris 120
Not applicableStudy completedNCT01935726
What this trial is testing

Pulmonary Fibrosis Contact Registry

Who this might be right for
Pulmonary Fibrosis of Any CausePrimary Supporters/Caretakers of Patients With Pulmonary Fibrosis
National Jewish Health 300
Not applicableStudy completedNCT04521426
What this trial is testing

Ventilator-associated Injury (VAI) in Chronic Home Mechanical Ventilation

Who this might be right for
Respiratory FailureLong-term Non-invasive Ventilation
University Medical Center Groningen 15
Early research (Phase 1)Looking for participantsNCT05988463
What this trial is testing

Dose-Escalation Study of Artesunate Patients With IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Joseph C. Wu 15
Not applicableLooking for participantsNCT06883448
What this trial is testing

Implementation of Home Monitoring in Patients With Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisInterstitial Lung Disease (ILD)
Erasmus Medical Center 220
Not applicableNot Yet RecruitingNCT07722507
What this trial is testing

Antifibrotic Therapy Decision-Making in Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisIdiopathic Pulmonary FibrosisProgressive Pulmonary Fibrosis
Bristol-Myers Squibb 40
Not applicableStudy completedNCT05779007
What this trial is testing

Dose Reduction and Discontinuation With Anti-Fibrotic Medications

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 2,778
Testing effectiveness (Phase 2)Study completedNCT02477709
What this trial is testing

Assess the Tolerability of a Single Dose of Gefapixant (AF-219/MK-7264) in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 6
Post-approval studies (Phase 4)Study completedNCT01744067
What this trial is testing

The Effects of Omega-3 Fatty Acids in Renal Transplantation

Who this might be right for
Disorder Related to Renal Transplantation
Oslo University Hospital 132
Not applicableLooking for participantsNCT01776398
What this trial is testing

Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)SmokingSmoking Cessation+3 more
Weill Medical College of Cornell University 2,000
Early research (Phase 1)Study completedNCT01254409
What this trial is testing

A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hoffmann-La Roche 21
Not applicableWithdrawnNCT05676112
What this trial is testing

Safety of Nintedanib in Real World in China

Who this might be right for
Pulmonary Fibrosis
Boehringer Ingelheim
Testing effectiveness (Phase 2)Ended earlyNCT06097260
What this trial is testing

Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Pliant Therapeutics, Inc. 320
Next Page